Author

T.-H. Lin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Ecology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1

Frequent Co-Authors

A. Antonelli· 1 shared A. Atemasov· 1 shared A. Ben David· 1 shared A. Cooper· 1 shared A. F. Cord· 1 shared A. Gasc· 1 shared A. L. Baucells· 1 shared A. Pegu· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEcology

A. Antonelli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Worldwide Soundscapes: a synthesis of passive acoustic monitoring across realms

K. F. Darras, R. Rountree, S. Van Wilgenburg, A. F. Cord, Y. Chen, L. Dong, A. Rocquencourt, C. Desjonqueres, P. M. Diaz, T.-H. Lin, A. Gasc, S. Marley, M. Salton, L. Schille, P. J. Wensveen, , B

The paper synthesizes passive acoustic monitoring data across ecosystems to assess global coverage and identify gaps in biodiversity monitoring.

bioRxiv · Apr 10, 2024Ecology

Broadly neutralizing antibodies target the coronavirus fusion peptide

C. Dacon, C. Tucker, L. Peng, C.-C. D. Lee, T.-H. Lin, M. Yuan, Y. Cong, L. Wang, L. Purser, J. K. Williams, C.-W. Pyo, I. Kosik, Z. Hu, M. Zhao, D. Mohan, , J. Tan

The paper identifies six monoclonal antibodies that broadly neutralize coronaviruses by targeting the conserved fusion peptide.

bioRxiv · Apr 11, 2022Immunology

Targeting BMI1 and MCL1 for Lung Adenocarcinoma Treatment

E.-H. Lin, C.-F. Hsu, Y.-H. Jan, T.-H. Lin, H.-Y. Chang, C.-M. Cheng, H.-J. Hsu, W.-W. Chen, B.-H. Chen, H.-F. Tsai, J.-J. Li, C.-Y. Huang, S.-H. Chuang, J.-M. Chang, M. Hsiao, C.-W. Wu

This study identifies BMI1 and MCL1 as key drivers of lung adenocarcinoma progression and demonstrates that targeting these proteins with a novel small-molecule inhibitor suppresses tumor growth in preclinical models.

bioRxiv · Oct 22, 2018 · PreprintCancer Biology